Literature DB >> 20064642

Pioglitazone improves endothelium-dependent vasodilation in hypertensive patients with impaired glucose tolerance in part through a decrease in oxidative stress.

Takayuki Hidaka1, Keigo Nakagawa, Chikara Goto, Junko Soga, Yuichi Fujii, Takaki Hata, Naomi Idei, Noritaka Fujimura, Kazuaki Chayama, Yasuki Kihara, Yukihito Higashi.   

Abstract

BACKGROUND: The aim of this study was to determine pioglitazone treatment restores endothelial function in hypertensive patients with impaired glucose tolerance (IGT). METHODS AND
RESULTS: We evaluated the effects of pioglitazone treatment for 12 weeks on forearm blood flow (FBF) responses to acetylcholine and sodium nitroprusside in 34 hypertensive patients with IGT who were randomly divided into a pioglitazone group (n=17) and an amlodipine monotherapy group (n=17) and in 34 healthy subjects. Pioglitazone, but not amlodipine, increased the FBF response to acetylcholine and decreased urinary excretion of 8-hydroxy-2'-deoxyguanosine. Pioglitazone did not alter sodium nitroprusside-stimulated vasodilation. NG-monomethyl-L-arginine abolished the augmentation of FBF response to acetylcholine after pioglitazone treatment. The increase in maximal FBF response to acetylcholine correlated with the decrease in urinary excretion of 8-hydroxy-2'-deoxyguanosine.
CONCLUSION: Pioglitazone improved endothelial function in hypertensive patients with IGT through an increase in nitric oxide bioavailability by, in part, a decrease in oxidative stress. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064642     DOI: 10.1016/j.atherosclerosis.2009.12.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection.

Authors:  William G Sanders; Huan Li; Ilya Zhuplatov; Yuxia He; Seong-Eun Kim; Alfred K Cheung; Jayant Agarwal; Christi M Terry
Journal:  J Control Release       Date:  2017-09-01       Impact factor: 9.776

Review 2.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

Review 3.  3-nitrotyrosine modified proteins in atherosclerosis.

Authors:  Leonor Thomson
Journal:  Dis Markers       Date:  2015-03-01       Impact factor: 3.434

4.  ABCG1 Attenuates Oxidative Stress Induced by H2O2 through the Inhibition of NADPH Oxidase and the Upregulation of Nrf2-Mediated Antioxidant Defense in Endothelial Cells.

Authors:  Jiahong Xue; Jiali Fan; Yuan Li; Wenhuan Wu; Qing Yan; Qiangsun Zheng
Journal:  Anal Cell Pathol (Amst)       Date:  2020-12-03       Impact factor: 2.916

5.  Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study.

Authors:  Tatsuya Maruhashi; Yukihito Higashi; Yasuki Kihara; Hirotsugu Yamada; Masataka Sata; Shinichiro Ueda; Masato Odawara; Yasuo Terauchi; Kazuoki Dai; Jun Ohno; Masato Iida; Hiroaki Sano; Hirofumi Tomiyama; Teruo Inoue; Atsushi Tanaka; Toyoaki Murohara; Koichi Node
Journal:  Cardiovasc Diabetol       Date:  2016-09-13       Impact factor: 9.951

6.  Pioglitazone ameliorates endothelial dysfunction in those with impaired glucose regulation among the first-degree relatives of type 2 diabetes mellitus patients.

Authors:  Xuemei Yu; Peihong Chen; Hongtao Wang; Tong Zhu
Journal:  Med Princ Pract       Date:  2012-09-04       Impact factor: 1.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.